Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs AXTX✓SelectedUSD · AXTXGSK vs AXTX performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs AXTX

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-4.6%
AXTX return
-97.1%
Excess return
+92.4%
Maximum drawdown
-13.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioAXTXExcessAlpha
1D-1.6%-4.4%+2.9%-1.7%
7D-4.7%-37.3%+32.6%-5.6%
30D-4.7%-71.4%+66.7%-6.4%
3M-8.8%-86.5%+77.7%-10.8%
6M-4.6%-97.5%+92.8%-5.2%
All-4.6%-97.1%+92.4%-5.2%

Cumulative growth

Daily Returns

Daily percentage return beside AXTX.

Daily Out/Under-Performance

Portfolio return minus AXTX return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × AXTX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded AXTX wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling